ET Medical Technology Co., Ltd, founded in 1999, has undergone 17-years growth to a public listed company in SHANGHAI Stock Exchange, China. Nowadays, ET is not only a manufacturer of medical devices, but also a medical service and finance support supplier. Our branches and cooperative institutions consist of a complete service and sales networks in China. And overseas branches are planning now. ET initially is a supplier of radiotherapy integrated solutions for oncology in China. Gamma Knife is the key product, which is developed and produced totally by ourselves. Gradually, we are developing other lines, such as liver health detection, thermotherapy, phototherapy, ultrasound detection and so on. All products were owned independent intellectual property rights. Meanwhile we have applied for more than 80 patents for the lines. So far, our products have been nearly introduced everywhere in the world. Since last year, Chinese government has vigorously advocated 'Internet+' national strategy. ET begins to market our products online to support this strategy. And ALIBABA is the best choice for initiate. Furthermore, Medical investment is another key business for us. ET has invested over 40 hospitals to establish cancer treatment centers in China, and this business is in processing. As well, we are planning and looking for overseas partners worldwide. 17 years are not short, nevertheless, there is a long way for ET to go. We hope our products and service always make our partners, customers and patients satisfied.
ET Medical Technology Co., Ltd, founded in 1999, has undergone 17-years growth to a public listed company in SHANGHAI Stock Exchange, China. Nowadays, ET is not only a manufacturer of medical devices, but also a medical service and finance support supplier. Our branches and cooperative institutions consist of a complete service and sales networks in China. And overseas branches are planning now. ET initially is a supplier of radiotherapy integrated solutions for oncology in China. Gamma Knife is the key product, which is developed and produced totally by ourselves. Gradually, we are developing other lines, such as liver health detection, thermotherapy, phototherapy, ultrasound detection and so on. All products were owned independent intellectual property rights. Meanwhile we have applied for more than 80 patents for the lines. So far, our products have been nearly introduced everywhere in the world. Since last year, Chinese government has vigorously advocated 'Internet+' national strategy. ET begins to market our products online to support this strategy. And ALIBABA is the best choice for initiate. Furthermore, Medical investment is another key business for us. ET has invested over 40 hospitals to establish cancer treatment centers in China, and this business is in processing. As well, we are planning and looking for overseas partners worldwide. 17 years are not short, nevertheless, there is a long way for ET to go. We hope our products and service always make our partners, customers and patients satisfied.